Kristen Fortney is the co-founder and CEO of BioAge Labs, a clinical-stage biotechnology company developing a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging. In this conversation with Stanford adjunct lecturer Toby Corey, Fortney discusses strategies for reducing risk along the path to developing world-changing therapies.
Related
Margo Georgiadis,
Flagship Pioneering
Deep Tech Innovation [Entire Talk]
By addressing risk and embracing uncertainty, deep tech entrepreneurs can create world-changing innovations.
Video
50 minutes
Margo Georgiadis,
Flagship Pioneering
Deep Tech Innovation [Entire Talk]
By addressing risk and embracing uncertainty, deep tech entrepreneurs can create world-changing innovations.
Sam Altman,
OpenAI
The Possibilities of AI [Entire Talk]
AI opportunities are just beginning. The future holds risks and rewards.
Video
46 minutes
Sam Altman,
OpenAI
The Possibilities of AI [Entire Talk]
AI opportunities are just beginning. The future holds risks and rewards.
Qasar Younis,
Applied Intuition
Radically Pragmatic Insights [Entire Talk]
Becoming a successful entrepreneur requires more than ambition.
Video
45 minutes
Qasar Younis,
Applied Intuition
Radically Pragmatic Insights [Entire Talk]
Becoming a successful entrepreneur requires more than ambition.